OpenVSafe by OpenVAERS
Search V-safe

3FX-31552-46463

2 vaccinations 7 coded responses 19 check-ins 7 free-text entries 0 call cases
Sex
Female
Age at first dose
31-35
ZIP prefix
997 / AK
Registered
2020-12-23
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2020-12-23
    Registered in v-safe
  2. 2020-12-23
    Dose 1 — Moderna
  3. 2020-12-23
    Survey response — day 0, dose 1
    MedDRA: Injection site discomfort — Feeling: Good
    Free text: Soreness (not pain) at injection site
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  4. 2020-12-24
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · Fatigue or tiredness
    Adult check-in
  5. 2020-12-25
    Survey response — days 1–6 daily, dose 1
    MedDRA: Fatigue, Injection site pain, Injection site swelling — Feeling: Good · Site: Pain
    Free text: Injection site pain is improving and swelling has diminished significantly. The fatigue noted the first day after injection continues to be resolved. No new or worsening symptoms have developed.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  6. 2020-12-26
    Survey response — days 1–6 daily, dose 1
    MedDRA: Injection site pain — Feeling: Good
    Free text: Resolving injection site soreness
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  7. 2020-12-30
    Survey response — day 7, dose 1
    MedDRA: Fatigue, Pain in extremity, Peripheral swelling — Feeling: Good
    Free text: Since I missed a check in or two- arm soreness resolved day 5 after vaccination. Day 1 the arm was very sore, leaning more towards pain. Also slightly swollen. These symptoms slowly decreased and resolved by day 5. Slight fatigue also noted day 1. Since day five, I have been feeling well and completing all daily activities without issue
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  8. 2021-01-13
    Health check-in — day 21, dose 1
    Feeling: Good
    Adult check-in
  9. 2021-01-25
    Dose 2 — Moderna
  10. 2021-01-25
    Survey response — day 0, dose 2
    MedDRA: Feeling hot — Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness
    Free text: Additionally feeling warm. Symptoms are more numerous, started sooner, and more intense then the same timeframe after the first dose.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  11. 2021-01-26
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activities
    Adult check-in
  12. 2021-01-27
    Survey response — days 1–6 daily, dose 2
    MedDRA: Adverse reaction, Loss of personal independence in daily activities, Self-medication — Feeling: Fair · Site: Pain, Swelling · Chills, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activities
    Free text: Sxs improved from yesterday but still impacting daily activities. Continuing to treat with NSAIDs.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  13. 2021-01-29
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  14. 2021-01-30
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  15. 2021-02-01
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  16. 2021-02-08
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  17. 2021-02-15
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  18. 2021-02-22
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  19. 2021-03-04
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  20. 2021-03-08
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  21. 2021-07-27
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  22. 2022-01-25
    Survey response — 12 months, dose 2
    MedDRA: SARS-CoV-2 test positive — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: Tested Positive for COVID
    MedDRA releases: 2024-11 · check-in free text available

Vaccinations

DoseDateManufacturerCo-administered
12020-12-23Moderna
22021-01-25Moderna

Free text

Release 1 — day 0, dose 1

2020-12-23

Systemic reaction (other): Soreness (not pain) at injection site

Release 1 — days 1–6 daily, dose 1

2020-12-25

Systemic reaction (other): Injection site pain is improving and swelling has diminished significantly. The fatigue noted the first day after injection continues to be resolved. No new or worsening symptoms have developed.

2020-12-26

Systemic reaction (other): Resolving injection site soreness

Release 1 — day 7, dose 1

2020-12-30

Systemic reaction (other): Since I missed a check in or two- arm soreness resolved day 5 after vaccination. Day 1 the arm was very sore, leaning more towards pain. Also slightly swollen. These symptoms slowly decreased and resolved by day 5. Slight fatigue also noted day 1. Since day five, I have been feeling well and completing all daily activities without issue

Release 2 — day 0, dose 2

2021-01-25

Systemic reaction (other): Additionally feeling warm. Symptoms are more numerous, started sooner, and more intense then the same timeframe after the first dose.

Release 2 — days 1–6 daily, dose 2

2021-01-27

Systemic reaction (other): Sxs improved from yesterday but still impacting daily activities. Continuing to treat with NSAIDs.

Release 11 — 12 months, dose 2

2022-01-25

Symptoms: Tested Positive for COVID

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDSARS-CoV-2 test positive · · ✓
SROAdverse reaction ✓ ✓ ✓
SROFatigue ✓ ✓ ✓
SROFeeling hot ✓ ✓ ✓
SROInjection site discomfort ✓ ✓ ✓
SROInjection site pain ✓ ✓ ✓
SROInjection site swelling ✓ ✓ ✓
SROLoss of personal independence in daily activities ✓ ✓ ✓
SROPain in extremity ✓ ✓ ✓
SROPeripheral swelling ✓ ✓ ✓
SROSelf-medication ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release